← Leaderboards
Susan Jick
New England Research Institutes, Inc.
$579,556
Attributed
$771,118
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $315.6K · FY2014–16$500K$375K$250K$125K$0
'14
'15
'16
Funding mix
By agency
NIH$771,118 · 2
By mechanism
R01$387,993 · 1
R21$383,125 · 1
Top collaborators
- Hozefa Divan1 shared
- Shona C Fang1 shared
Most similar at New England Research Institutes, Inc.
Same institution · by research overlap
- Susan Audrey Hall$1,144,784
- Catherine B Johannes$1,131,747
- Andre B. Araujo$3,726,863
- Maria Irene Van Rompay$296,068
- Shona C Fang$137,688
Others in their field
Top investigators on “Neurosecretory Systems”
- Carol D. Ryff · University Of Wisconsin Madison$35,507,320
- J. Mark Cline · Wake Forest University$20,130,326
- Suzanne M Moenter · University Of Michigan At Ann Arbor$19,116,620
- Maurizio Fava · Massachusetts General Hospital$19,116,294
- Jill M Goldstein · Massachusetts General Hospital$16,162,892
- William S Kremen · University Of California Davis$14,388,979
Research focus
Neurosecretory SystemsIncidenceCostMental DepressionMedicalSafetyAccountingComputerized Medical RecordFollow-UpMedical RecordsPharmacoepidemiologyPharmaceutical PreparationsResearch DesignRisk FactorsBaseBehavioralClinical PracticeCohort StudiesDatabasesDosePublic Health Medicine (Field)Public Health RelevanceAwarenessAutism Spectrum Disorder
Grant awards (4)
Maternal Depression and Antidepressant Use During Pregnancy and Risk of Childhood Autism Spectrum Disorders in Offspring: Population-Based Cohort and Bidirectional Case-Crossover Sibling Study$180,093
R01 · FY2016 · HD · contact PI
Maternal Depression and Antidepressant Use During Pregnancy and Risk of Childhood Autism Spectrum Disorders in Offspring: Population-Based Cohort and Bidirectional Case-Crossover Sibling Study$207,900
R01 · FY2015 · HD · contact PI
An Epidemiologic Evaluation of Adverse Events of 5-Alpha-Reductase Inhibitors$107,750
R21 · FY2015 · DK
An Epidemiologic Evaluation of Adverse Events of 5-Alpha-Reductase Inhibitors$275,375
R21 · FY2014 · DK